查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618742

神經調節市場：按技術、按應用分類 - 2025-2030 年全球預測

Neuromodulation Market by Technology (Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation), Application (Chronic Pain, Dystonia, Essential Tremor) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年神經調節市場價值為77.6億美元，預計到2024年將達到86.1億美元，複合年成長率為11.50%，到2030年將達到166.2億美元。

作為醫學領域的先鋒領域，調查方法包括直接影響神經以達到治療效果的技術和方法，透過電刺激或標靶藥物傳遞來改變神經活動。這種需求源於日益增加的神經系統疾病、慢性疼痛綜合症和人口老化，從而產生了對有效管理解決方案的需求。應用包括慢性疼痛管理、癲癇、帕金森氏症、憂鬱症和目標肌肉疾病。最終使用情境通常包括使用脊髓刺激設備、迷走神經刺激設備、深層腦部刺激器等的醫院、診所和居家照護環境。市場動態表明，技術進步、意識提升和醫療保健支出增加等關鍵影響因素正在推動成長。微創手術的增加提供了利潤豐厚的可能性，並代表了新市場進入的前沿。此外，醫療保健框架不斷完善的新興國家也帶來了尚未開發的商機。然而，高昂的設備成本、複雜的法規環境以及潛在的副作用等限制限制了市場的快速擴張。另一個問題是，現有公司正在獲得先發優勢，並阻礙新進入。在創新方面，穿戴式神經調節器和透過人工智慧實現的個人化治療方法凸顯了豐富的研究途徑，有望顛覆傳統做法。此外，將物聯網整合到神經系統應用中進行遠端監控有可能重新定義患者的互動和結果。市場的動態性和保守性要求產品開發和策略夥伴關係關係的敏捷性，以佔領市場佔有率。為了利用這些機會，鼓勵企業投資符合監管合規性的強力的舉措，並強調與高科技公司的合作，以整合數位技術的進步。總體而言，神經調節市場面臨障礙，但在連接創新解決方案和臨床療效以實現持續業務成長方面存在巨大潛力。

主要市場統計
基準年[2023] 77.6億美元
預測年份 [2024] 86.1億美元
預測年份 [2030] 166.2億美元
複合年成長率（%） 11.50%

市場動態：揭示快速發展的神經調節市場的關鍵市場洞察

供需的動態交互作用正在改變神經調節市場。了解這些不斷變化的市場動態可以幫助公司做出明智的投資決策、改善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 世界人口老化加劇和神經系統疾病蔓延
    • 神經刺激系統和神經調節解決方案的研究計劃和臨床測試
    • 政府努力擴大神經系統疾病和失調的治療方法機會
  • 市場限制因素
    • 神經調節和神經刺激設備系統發生產品召回
  • 市場機會
    • 最佳化神經調節策略效率與安全性的創新
    • 世界各地正在核准神經調節設備和治療方法
  • 市場問題
    • 該技術的侵入性和技術限制

波特五力：駕馭神經調節市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解神經調節市場的外在影響

外部宏觀環境因素在塑造神經調節市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解神經調節市場的競爭格局

對神經調節市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣：神經調節市場供應商績效評估

FPNV定位矩陣是評估神經調節市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃神經調節市場的成功之路

神經調節市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化和神經系統疾病在世界各地變得越來越普遍。
      • 神經刺激系統和解決方案的研究舉措和臨床測試
      • 政府努力擴大神經系統疾病和失調的治療方法範圍
    • 抑制因素
      • 神經調節和神經刺激設備或系統的產品回收數量
    • 機會
      • 最佳化神經調節策略效率與安全性的創新
      • 世界各地正在核准神經調節設備和治療方法
    • 任務
      • 該技術的侵入性和技術限制
  • 市場區隔分析
    • 技術：對於運動障礙和精神疾病的深部腦部刺激療法的需求日益成長。
    • 用途：全球帕金森氏症發病率增加
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章神經調節市場：依技術分類

  • 介紹
  • 腦深部電刺激療法
  • 胃刺激
  • 薦椎神經刺激
  • 脊髓刺激
  • 迷走神經刺激

第7章神經調節市場：依應用分類

  • 介紹
  • 慢性疼痛
  • 肌張力不全症
  • 自發性震顫
  • 胃輕癱
  • 強迫性精神官能症
  • 帕金森氏症
  • 難治性癲癇
  • 抗治療性憂鬱症
  • 尿失禁

第8章美洲神經調節市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太神經調節市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲神經調節市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • GrayMatters Health 在美國推出經 FDA核准的新的自我神經調節 PTSD治療方法
    • Reddy 博士在印度推出用於偏頭痛管理的穿戴式設備
    • Galderma 在 Liquid實況活動中展示了大膽的神經調節雄心
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • BioControl by Merck
  • BioElectronics Corporation
  • Boston Scientific Corporation
  • Dr Reddys Laboratories Limited
  • EndoStim, Inc.
  • Galderma SA
  • GrayMatters Health
  • Impulse Dynamics
  • Livanova
  • Mainstay Medical
  • Medtronic PLC
  • MicroTransponde
  • NeuroMetrix
  • Neuronetics, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Nevro Corp.
  • Saluda Medical
  • SceneRay Corporation, Limited
  • Soterix Medical
  • Synapse Biomedical
Product Code: MRR-036C5CF3B4DB

The Neuromodulation Market was valued at USD 7.76 billion in 2023, expected to reach USD 8.61 billion in 2024, and is projected to grow at a CAGR of 11.50%, to USD 16.62 billion by 2030.

Neuromodulation, a pioneering domain in the medical field, encompasses technologies and methodologies that directly act upon nerves to achieve a therapeutic effect, thus altering nerve activity through targeted delivery of electrical stimulation or pharmaceutical agents. Its necessity arises from rising neurological disorders, chronic pain syndromes, and an aging population, creating an imperative for effective management solutions. The application spectrum includes chronic pain management, epilepsy, Parkinson's disease, depression, and targeted muscle disorders. End-use scenarios often feature hospitals, clinics, and in-home care settings that leverage spinal cord stimulators, vagus nerve stimulators, and deep brain stimulators. Market dynamics reveal key influencers such as technological advancements, increasing patient awareness, and heightened healthcare expenditure which boost growth. The escalation of minimally invasive surgeries offers lucrative potential and marks a frontier for new market entrants. Furthermore, emergent economies with improving healthcare frameworks present untapped opportunities. However, limitations such as high device costs, complex regulatory environments, and potential side effects restrict rapid market expansion. Challenges also stem from first-mover advantages held by established players, inhibiting newer entrants. Innovatively, wearable neuromodulators and AI-driven personalization of treatment regimens highlight fertile research avenues poised to disrupt traditional practices. Additionally, the integration of IoT for remote monitoring in neural applications could redefine patient interactions and outcomes. The market holds a dynamic yet conservative nature, where nimbleness in product development and strategic partnerships is critical to captivate market share. Businesses are encouraged to invest in robust R&D initiatives that align with regulatory compliances to harness these opportunities, emphasizing collaborations with tech firms to integrate digital advancements. Overall, while the neuromodulation market faces hurdles, its vast potential lies in bridging innovative solutions with clinical efficacy for sustained business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 7.76 billion
Estimated Year [2024] USD 8.61 billion
Forecast Year [2030] USD 16.62 billion
CAGR (%) 11.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neuromodulation Market

The Neuromodulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the aging population across the world and prevalence of neurological disorders
    • Research initiatives and clinical trials for neurostimulation systems and neuromodulation solutions
    • Government initiatives to expand access to therapies for neurological diseases and disorders
  • Market Restraints
    • Incidences of product recall of neuromodulation and neurostimulation devices or systems
  • Market Opportunities
    • Innovations to optimize the efficiency and safety of neuromodulation strategies
    • Ongoing approvals for neuromodulation devices and treatments across the world
  • Market Challenges
    • Invasiveness and technical limitations of the technology

Porter's Five Forces: A Strategic Tool for Navigating the Neuromodulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neuromodulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neuromodulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neuromodulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neuromodulation Market

A detailed market share analysis in the Neuromodulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neuromodulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neuromodulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neuromodulation Market

A strategic analysis of the Neuromodulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neuromodulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BioControl by Merck, BioElectronics Corporation, Boston Scientific Corporation, Dr Reddys Laboratories Limited, EndoStim, Inc., Galderma S.A., GrayMatters Health, Impulse Dynamics, Livanova, Mainstay Medical, Medtronic PLC, MicroTransponde, NeuroMetrix, Neuronetics, Inc., NeuroPace, Inc., NeuroSigma, Inc., Nevro Corp., Saluda Medical, SceneRay Corporation, Limited, Soterix Medical, and Synapse Biomedical.

Market Segmentation & Coverage

This research report categorizes the Neuromodulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation.
  • Based on Application, market is studied across Chronic Pain, Dystonia, Essential Tremor, Gastroparesis, Obsessive Compulsive Disorder, Parkinson's Disease, Refractory Epilepsy, Treatment Resistant Depression, and Urinary Fecal Incontinence.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the aging population across the world and prevalence of neurological disorders
      • 5.1.1.2. Research initiatives and clinical trials for neurostimulation systems and neuromodulation solutions
      • 5.1.1.3. Government initiatives to expand access to therapies for neurological diseases and disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recall of neuromodulation and neurostimulation devices or systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations to optimize the efficiency and safety of neuromodulation strategies
      • 5.1.3.2. Ongoing approvals for neuromodulation devices and treatments across the world
    • 5.1.4. Challenges
      • 5.1.4.1. Invasiveness and technical limitations of the technology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Increasing need for deep brain stimulation therapies for movement disorders and psychiatric issues
    • 5.2.2. Application: Rising incidences of Parkinson's disease across the world
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neuromodulation Market, by Technology

  • 6.1. Introduction
  • 6.2. Deep Brain Stimulation
  • 6.3. Gastric Stimulation
  • 6.4. Sacral Nerve Stimulation
  • 6.5. Spinal Cord Stimulation
  • 6.6. Vagus Nerve Stimulation

7. Neuromodulation Market, by Application

  • 7.1. Introduction
  • 7.2. Chronic Pain
  • 7.3. Dystonia
  • 7.4. Essential Tremor
  • 7.5. Gastroparesis
  • 7.6. Obsessive Compulsive Disorder
  • 7.7. Parkinson's Disease
  • 7.8. Refractory Epilepsy
  • 7.9. Treatment Resistant Depression
  • 7.10. Urinary Fecal Incontinence

8. Americas Neuromodulation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Neuromodulation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Neuromodulation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. GrayMatters Health Launches New FDA-Cleared Self-Neuromodulation PTSD Therapy in the United States
    • 11.3.2. Dr. Reddy's Unveils Wearable for Migraine Management in India
    • 11.3.3. Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BioControl by Merck
  • 3. BioElectronics Corporation
  • 4. Boston Scientific Corporation
  • 5. Dr Reddys Laboratories Limited
  • 6. EndoStim, Inc.
  • 7. Galderma S.A.
  • 8. GrayMatters Health
  • 9. Impulse Dynamics
  • 10. Livanova
  • 11. Mainstay Medical
  • 12. Medtronic PLC
  • 13. MicroTransponde
  • 14. NeuroMetrix
  • 15. Neuronetics, Inc.
  • 16. NeuroPace, Inc.
  • 17. NeuroSigma, Inc.
  • 18. Nevro Corp.
  • 19. Saluda Medical
  • 20. SceneRay Corporation, Limited
  • 21. Soterix Medical
  • 22. Synapse Biomedical

LIST OF FIGURES

  • FIGURE 1. NEUROMODULATION MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROMODULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROMODULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEUROMODULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEUROMODULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROMODULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROMODULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROMODULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROMODULATION MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROMODULATION MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDONESIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. INDONESIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. JAPAN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. JAPAN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MALAYSIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MALAYSIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. PHILIPPINES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. PHILIPPINES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. SINGAPORE NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. SINGAPORE NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. SOUTH KOREA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. SOUTH KOREA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. TAIWAN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. TAIWAN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. THAILAND NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. THAILAND NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. VIETNAM NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. VIETNAM NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. DENMARK NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. DENMARK NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. EGYPT NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. EGYPT NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. FINLAND NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. FINLAND NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. FRANCE NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. FRANCE NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. GERMANY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. GERMANY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ISRAEL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. ISRAEL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. ITALY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. ITALY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NETHERLANDS NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. NETHERLANDS NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. NIGERIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. NIGERIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. NORWAY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. NORWAY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. POLAND NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. POLAND NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. QATAR NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. QATAR NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. RUSSIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. RUSSIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SAUDI ARABIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SAUDI ARABIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH AFRICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH AFRICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SPAIN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. SPAIN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SWEDEN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. SWEDEN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SWITZERLAND NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SWITZERLAND NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. TURKEY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. TURKEY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NEUROMODULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 110. NEUROMODULATION MARKET, FPNV POSITIONING MATRIX, 2023